2315 — Biocytogen Pharmaceuticals Beijing Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.89bn
- HK$4.05bn
- CNY716.91m
Annual cashflow statement for Biocytogen Pharmaceuticals Beijing Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -477 | -546 | -601 | -380 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 237 | 61.9 | 27.5 | 131 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -29.2 | -10.2 | 96.5 | -9.88 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -225 | -366 | -303 | -76.6 |
| Capital Expenditures | -296 | -199 | -240 | -127 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 108 | 115 | 86.5 | 26.3 |
| Acquisition of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -188 | -84.1 | -154 | -100 |
| Financing Cash Flow Items | 889 | 234 | 448 | -177 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 868 | 219 | 587 | -37.8 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 451 | -231 | 144 | -211 |